Skills

People expertise

  • Richard Begent
    Gastrointestinal cancer, antibody targeted therapy & imaging biomedical informatics
  • Chris Boshoff
    Sarcoma, head and neck cancer, Kaposi's sarcoma, tumour virology, molecular oncology
  • Stephen Bown
    Laser therapy
  • John Bridgewater
    Gastrointestinal cancer, translational research linked to Phase III clinical trials
  • Martyn Caplin
    Neuroendocrine cancer
  • David Chao
    Melanoma, renal cancer, biological therapy
  • Kerry Chester
    Protein and antibody engineering, proteomics by mass spectroscopy, novel therapies
  • Mary Collins
    Gene therapy
  • Peter Ell
    Nuclear medicine, novel imaging for diagnosis and response assessment in cancer patients
  • Alan Green
    Medical Physics, SPECT imaging, mathematical modelling
  • John Hartley
    DNA damage and repair
  • Daniel Hochhauser
    Gastrointestinal cancer, DNA interacting agents, EGFR
  • Ian Jacobs
    Gynaecological cancer, ovarian cancer screening
  • Jonathan Ledermann
    Gynaecological cancer, translational research in clinical trials
  • David Linch
    Haematology, haematological malignancies
  • Laurence Lovat
    Oesophageal cancer and Barrett's oesophagus, early diagnosis treatment of pre-malignant disease
  • Stephen Mackinnon
    Haematology, immunotherapy & stem cell transplantation
  • John Masters
    Prostate cancer, stem cells, molecular pathology
  • Astrid Mayer
    Gastrointestinal cancer, antibody targeted therapy & imaging, biomedical informatics
  • Tim Meyer
    Gastrointestinal cancer, antivascular therapy, cell adhesion molecules
  • Antony Michalski
    Paediatric cancer
  • Sylvia Nagl
    Cancer systems science, biomedical Informatics & data modelling
  • Marco Novelli
    Pathology, novel prognostic markers for diagnosis and prognosis
  • Barbara Pedley
    Tumour biology, microscopy imaging systems, pre-clinical therapeutics (antibody-targeted therapy & anti-vascular drugs)
  • Stephen Pereira
    Hepatobiliary cancer, photodynamic therapy, novel prognostic markers
  • Michele Saunders
    Head and neck cancer, radiotherapy fractionation, Phase I radiation therapy trials
  • Susan Short
    Neuro-oncology, radiotherapy fractionation, Phase I trials
  • Hans Stauss
    Cancer immunology, T-cell therapy
  • Martin Widschwendter
    Gynaecological cancer, epigenetics
  • Gareth Williams
    Pathology, DNA replication licensing
  • Surinder Sharma
    Antibody Directed Enzyme Prodrug Therapies (ADEPT), pre-clinical and translational therapeutics, GCLP for clinical PK and PD, immunogenicity of protein therapeutics
  • Geoffrey Boxer
    Pathology, administration
  • Helen MacColl
    Co-ordinator/administration
  • Carmel Hopkins
    Administration